These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3034139)

  • 21. Thyrotropin-releasing hormone blocks the hypotensive effects of platelet-activating factor in the unanesthetized guinea pig.
    Feuerstein G; Lux WE; Ezra D; Hayes EC; Snyder F; Faden AI
    J Cardiovasc Pharmacol; 1985; 7(2):335-40. PubMed ID: 2581089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma.
    Kay AB
    Eur J Respir Dis Suppl; 1983; 129():1-44. PubMed ID: 6418559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of substance P on the arachidonate cascade of rat platelets.
    Kis B; Mezei Z; Gecse A; Telegdy G
    Acta Physiol Hung; 1997-1998; 85(2):89-97. PubMed ID: 9706302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of platelet-activating factor-induced cardiac depression in the isolated perfused rat heart.
    Stahl GL; Lefer AM
    Circ Shock; 1987; 23(3):165-77. PubMed ID: 2827906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PAF-acether and leukotriene participation in acute circulatory shock.
    Bessin P
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():139-50. PubMed ID: 3774841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
    O'Flaherty JT
    J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-activating factor stimulates multiple signaling pathways in cultured rat mesangial cells.
    Kester M; Thomas CP; Wang J; Dunn MJ
    J Cell Physiol; 1992 Nov; 153(2):244-55. PubMed ID: 1331121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
    Morris DD; Moore JN
    Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacology of the leukotrienes].
    Sirois P; Borgeat P
    J Pharmacol; 1984; 15 Suppl 1():53-68. PubMed ID: 6328128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of eicosanoids in mediating blood flow alterations in endotoxin shock.
    Tempel GE; Strong JW; Wise WC; Cook JA; Smith EF; Halushka PV
    Prog Clin Biol Res; 1989; 299():33-42. PubMed ID: 2498907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel enhancing effect of platelet activating factor (PAF) on glucose oxidation in uteri from pregnant rats. Participation of prostaglandins and leukotrienes.
    González E; Gimeno AL; Gimeno MA
    Prostaglandins Leukot Essent Fatty Acids; 1990 May; 40(1):79-84. PubMed ID: 2399270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukotrienes as mediators of ischemia and shock.
    Lefer AM
    Biochem Pharmacol; 1986 Jan; 35(2):123-7. PubMed ID: 3002383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effect of a PAF antagonist CV-3988 on active and passive anaphylactic shock in various mouse strains.
    Arimura A; Harada M
    Lipids; 1991 Dec; 26(12):1386-90. PubMed ID: 1819738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung.
    Uhlig S; Göggel R; Engel S
    Pharmacol Rep; 2005; 57 Suppl():206-21. PubMed ID: 16415501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of some prostaglandins and prostaglandin analogues on PAF-induced shock in mice.
    Becker K; Herfurth ML; Schillinger E; Förster W
    Prostaglandins Leukot Essent Fatty Acids; 1990 Jun; 40(2):157-60. PubMed ID: 1696744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukotrienes in health and disease.
    Feuerstein G; Hallenbeck JM
    FASEB J; 1987 Sep; 1(3):186-92. PubMed ID: 3040505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between myocardial depressant factor and vasoactive mediators with ischemia and shock.
    Lefer AM
    Am J Physiol; 1987 Feb; 252(2 Pt 2):R193-205. PubMed ID: 3544878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-activating factor (PAF) and its relation to prostaglandins, leukotrienes and other aspects of arachidonate metabolism.
    Peplow PV; Mikhailidis DP
    Prostaglandins Leukot Essent Fatty Acids; 1990 Oct; 41(2):71-82. PubMed ID: 2274568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of leukotrienes in endotoxin action in vivo.
    Keppler D; Hagmann W; Rapp S
    Rev Infect Dis; 1987; 9 Suppl 5():S580-4. PubMed ID: 3317751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signal transduction and gene expression in the eye: a contemporary view of the pro-inflammatory, anti-inflammatory and modulatory roles of prostaglandins and other bioactive lipids.
    Bazan NG; Allan G
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S23-34. PubMed ID: 9154273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.